{"References": [{"title": "Engineering therapeutic antibodies for improved function", "authors": "Jeffrey V. Ravetch, Falk Nimmerjahn", "journal": "Biochemical Society Transactions", "year": "2009", "volumes": "37", "first page": "1006", "last page": "1010", "DOI": "10.1042/BST0371006"}, {"title": "Fc engineering of therapeutic antibodies for enhanced half-life and improved effector functions", "authors": "Janice M. Reichert", "journal": "mAbs", "year": "2012", "volumes": "4", "first page": "217", "last page": "219", "DOI": "10.4161/mabs.4.2.19284"}, {"title": "Bispecific antibodies: a mechanistic review of the pipeline", "authors": "Marion Bacac, Christian Klein, Christian Umana", "journal": "Nature Reviews Drug Discovery", "year": "2016", "volumes": "15", "first page": "585", "last page": "608", "DOI": "10.1038/nrd.2016.78"}, {"title": "Antibodyâ€“drug conjugates: an emerging concept in cancer therapy", "authors": "Hans Peter Gerber, Janice M. Reichert, Ira Pastan", "journal": "Angewandte Chemie International Edition", "year": "2014", "volumes": "53", "first page": "3796", "last page": "3827", "DOI": "10.1002/anie.201307628"}, {"title": "Passive antibody therapy for infectious diseases", "authors": "Robert A. Seder, Barney S. Graham", "journal": "Nature Reviews Microbiology", "year": "2009", "volumes": "7", "first page": "593", "last page": "602", "DOI": "10.1038/nrmicro2119"}, {"title": "Therapeutic antibodies: market considerations, disease targets and bioprocessing", "authors": "Janice M. Reichert", "journal": "International Journal of Biotechnology", "year": "2013", "volumes": "13", "first page": "1", "last page": "28", "DOI": "10.1504/IJBT.2013.050000"}, {"title": "Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond", "authors": "Jeffrey V. Ravetch, Falk Nimmerjahn", "journal": "Nature Reviews Drug Discovery", "year": "2012", "volumes": "11", "first page": "260", "last page": "276", "DOI": "10.1038/nrd3669"}, {"title": "Bispecific antibodies come of age", "authors": "Christian Klein, Marion Bacac, Christian Umana", "journal": "Nature Reviews Drug Discovery", "year": "2013", "volumes": "12", "first page": "95", "last page": "109", "DOI": "10.1038/nrd3912"}, {"title": "Antibody engineering for the development of therapeutic antibodies", "authors": "Janice M. Reichert, Paul J. Carter", "journal": "Molecular Cancer Therapeutics", "year": "2004", "volumes": "3", "first page": "145", "last page": "159", "DOI": "10.1158/1535-7163.145.3.11"}, {"title": "Therapeutic antibodies: successes, limitations and hopes for the future", "authors": "Janice M. Reichert, Paul J. Carter, Ira Pastan", "journal": "British Journal of Pharmacology", "year": "2009", "volumes": "157", "first page": "220", "last page": "233", "DOI": "10.1111/j.1476-5381.2009.00190.x"}]}